Find therapies in clinical trials near you – page 64

Study on the Safety of Migalastat for Patients with Fabry Disease and Severe Kidney Problems on Dialysis

Study on the Safety and Effects of AZD4831 for Adults with Non-Cirrhotic Non-Alcoholic Steatohepatitis (NASH) with Fibrosis

Study on the Safety and Effects of AZD4831 for Adults with Non-Cirrhotic Non-Alcoholic Steatohepatitis (NASH) with Fibrosis

Study of Pembrolizumab and Cisplatin for Patients with Stage III-IVA Resectable Head and Neck Cancer

Study of Pembrolizumab and Cisplatin for Patients with Stage III-IVA Resectable Head and Neck Cancer

Study on Trehalose Dihydrate for Treating Spinocerebellar Ataxia in Adults

Study on Trehalose Dihydrate for Treating Spinocerebellar Ataxia in Adults

Study on Tecovirimat for Treating Monkeypox in Patients with Confirmed Infection

Study on Tecovirimat for Treating Monkeypox in Patients with Confirmed Infection

Study of Pembrolizumab as Additional Treatment for Patients with High-Risk Locally Advanced Cutaneous Squamous Cell Carcinoma After Surgery and Radiation

Study of Pembrolizumab as Additional Treatment for Patients with High-Risk Locally Advanced Cutaneous Squamous Cell Carcinoma After Surgery and Radiation

Study of Pembrolizumab for Patients with Advanced Solid Tumors

Study of Pembrolizumab for Patients with Advanced Solid Tumors

Study of Pembrolizumab and Chemotherapy for Patients with Triple Negative Breast Cancer

Study of Pembrolizumab and Chemotherapy for Patients with Triple Negative Breast Cancer

Study on Selexipag and Bosentan for Children with Pulmonary Arterial Hypertension

Study on Selexipag and Bosentan for Children with Pulmonary Arterial Hypertension

Study of Pembrolizumab in Patients with Esophageal Cancer Undergoing Chemoradiotherapy

Study of Pembrolizumab in Patients with Esophageal Cancer Undergoing Chemoradiotherapy

Study on Overactive Bladder Treatment for Women Using Clostridium Botulinum Neurotoxin Type A and Vibe System

Study on Overactive Bladder Treatment for Women Using Clostridium Botulinum Neurotoxin Type A and Vibe System

Study of Datopotamab Deruxtecan and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer with Low PD-L1 Levels

Study of Datopotamab Deruxtecan and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer with Low PD-L1 Levels